United States Biotechnology & Medical Research

Celldex Therapeutics Inc (CLDX)

Track

Insider trading activity at Celldex Therapeutics Inc. has been characterized by periodic sales from company officers. The most recent transactions occurred on December 4, 2025, involving the sale of 4,166 shares by SVP and General Counsel Freddy A. Jimenez. Prior to this, Richard M. Wright executed a sale of 49,298 shares on November 13, 2025.
Ticker: CLDX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Celldex Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 4 Dec 2025
Value US$4,848,147.01 | Price 95.97 | Shares 80,552 (+24.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-08 2025-12-04 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
80,552 +24.6%
95.97
US$4,848,147 		80,552 +24.6% 95.97 US$4,848,147
2025-12-04 2025-12-04 PrS Proposed sale
2.3
FREDDY A JIMENEZ

Officer

Officer
75,837
316.07
US$1,984,362 		75,837 316.07 US$1,984,362
2025-11-17 2025-11-13 S Sale
2.2
Wright Richard M.
17,828 +36.1%
129.29
US$3,997,656 		17,828 +36.1% 129.29 US$3,997,656
2025-11-13 2025-11-13 PrS Proposed sale
2.2
RICHARD M WRIGHT

Officer

Officer
49,298
24.00
US$1,183,177 		49,298 24.00 US$1,183,177
2025-08-15 2025-08-13 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
430 -1.2%
25.42
US$10,928 		430 -1.2% 25.42 US$10,928
2025-08-15 2025-08-13 PlS Planned sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
341 -1.0%
23.95
US$8,167 		341 -1.0% 23.95 US$8,167
2024-11-12 2024-11-11 PP Planned purchase
2.4
Marucci Anthony S

PRESIDENT & CEO

Executive Director
11,500 +40.0%
26.82
US$308,430 		11,500 +40.0% 26.82 US$308,430
2024-06-18 2024-06-14 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
30,000 -76.8%
34.87
US$1,045,962 		30,000 -76.8% 34.87 US$1,045,962
2024-06-18 2024-06-14 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
17,172 -37.9%
35.42
US$608,315 		17,172 -37.9% 35.42 US$608,315
2024-06-14 2024-06-14 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
30,000
34.00
US$1,020,000 		30,000 34.00 US$1,020,000
2024-06-14 2024-06-14 PrS Proposed sale
2.1
Martin Samuel Bates

Officer

Officer
17,172
34.00
US$583,848 		17,172 34.00 US$583,848
2024-06-11 2024-06-07 S Sale
3.1
Young Diane C.

SVP, CHIEF MEDICAL OFFICER

Officer
45,000 -95.5%
35.26
US$1,586,844 		45,000 -95.5% 35.26 US$1,586,844
2024-06-11 2024-06-07 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
15,000 -62.3%
35.06
US$525,873 		15,000 -62.3% 35.06 US$525,873
2024-06-07 2024-06-07 PrS Proposed sale
3.1
Young Diane C.

Officer

Officer
45,000
35.26
US$1,586,843 		45,000 35.26 US$1,586,843
2024-06-07 2024-06-07 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
15,000
34.00
US$510,000 		15,000 34.00 US$510,000
2024-06-05 2024-06-03 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
19,264 -48.0%
33.99
US$654,695 		19,264 -48.0% 33.99 US$654,695
2024-06-05 2024-06-03 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
27,580 -40.8%
33.53
US$924,658 		27,580 -40.8% 33.53 US$924,658
2024-06-05 2024-06-03 S Sale
2.3
Jimenez Freddy A.

SVP & GENERAL COUNSEL

Officer
8,006 -23.6%
33.60
US$269,002 		8,006 -23.6% 33.60 US$269,002
2024-06-05 2024-06-03 S Sale
2.7
Heath-Chiozzi Margo

SVP OF REGULATORY AFFAIRS

Officer
58,369 -81.3%
33.65
US$1,964,088 		58,369 -81.3% 33.65 US$1,964,088
2024-06-03 2024-06-03 PrS Proposed sale
2.3
Jimenez Freddy A.

Officer

Officer
8,006
33.60
US$269,002 		8,006 33.60 US$269,002
2024-06-03 2024-06-03 PrS Proposed sale
2.2
Wright Richard M.

Officer

Officer
46,844
32.00
US$1,499,008 		46,844 32.00 US$1,499,008
2024-06-03 2024-05-30 S Sale
1.7
Crowley Elizabeth

SR. VP & CPDO

Officer
38,597 -81.0%
33.64
US$1,298,384 		38,597 -81.0% 33.64 US$1,298,384
2024-06-03 2024-05-30 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
20,853 -91.8%
33.73
US$703,334 		20,853 -91.8% 33.73 US$703,334
2024-06-03 2024-05-30 S Sale
2.7
Heath-Chiozzi Margo

SVP OF REGULATORY AFFAIRS

Officer
38,719 -84.5%
34.07
US$1,319,156 		38,719 -84.5% 34.07 US$1,319,156
2024-06-03 2024-05-30 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
35,000 -58.2%
34.05
US$1,191,774 		35,000 -58.2% 34.05 US$1,191,774
2024-05-30 2024-05-30 PrS Proposed sale
3.0
Cavanaugh Sarah

Officer

Officer
20,853
33.73
US$703,334 		20,853 33.73 US$703,334
2024-05-30 2024-05-30 PrS Proposed sale
2.1
Martin Samuel Bates

Officer

Officer
35,000
34.05
US$1,191,771 		35,000 34.05 US$1,191,771
2024-05-30 2024-05-30 PrS Proposed sale
1.7
Crowley Elizabeth

Officer

Officer
38,597
3.73
US$144,004 		38,597 3.73 US$144,004
2024-05-30 2024-05-30 PrS Proposed sale
2.7
Heath-Chiozzi Margo

Director

Non-Executive Director
97,088
36.32
US$3,526,236 		97,088 36.32 US$3,526,236
2022-12-09 2022-12-07 S Sale
2.7
KELER TIBOR

EXECUTIVE VP & CSO

Officer
16,860 -69.6%
36.93
US$622,611 		16,860 -69.6% 36.93 US$622,611
2022-08-19 2022-08-18 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
1,355 -51.3%
36.38
US$49,289 		1,355 -51.3% 36.38 US$49,289
2022-08-19 2022-08-17 S Sale
3.1
Young Diane C.

SVP, CHIEF MEDICAL OFFICER

Officer
19,000 -90.0%
37.30
US$708,715 		19,000 -90.0% 37.30 US$708,715
2022-08-19 2022-08-17 S Sale
3.0
Cavanaugh Sarah

SVP OF CORP AFFAIRS & ADMIN.

Officer
31,312 -96.1%
36.73
US$1,150,221 		31,312 -96.1% 36.73 US$1,150,221
2022-08-17 2022-08-15 S Sale
2.4
Marucci Anthony S

PRESIDENT & CEO

Executive Director
120,000 -81.3%
37.66
US$4,519,572 		120,000 -81.3% 37.66 US$4,519,572
2022-08-17 2022-08-15 S Sale
2.2
Wright Richard M.

SR. VP & CCO

Officer
15,328 -98.7%
37.71
US$578,048 		15,328 -98.7% 37.71 US$578,048
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
1,221 -4.8%
34.62
US$42,272 		1,221 -4.8% 34.62 US$42,272
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
2,065 -7.5%
35.38
US$73,053 		2,065 -7.5% 35.38 US$73,053
2022-08-15 2022-08-12 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
14,261 -34.0%
36.76
US$524,304 		14,261 -34.0% 36.76 US$524,304
2022-08-15 2022-08-11 S Sale
2.1
Martin Samuel Bates

SVP AND CFO

Officer
2,453 -9.1%
37.04
US$90,856 		2,453 -9.1% 37.04 US$90,856
2021-12-10 2021-12-08 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
7,323 -94.7%
40.00
US$292,920 		7,323 -94.7% 40.00 US$292,920
2021-12-10 2021-12-08 PlS Planned sale
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
600 -5.1%
40.00
US$24,000 		600 -5.1% 40.00 US$24,000
2021-12-10 2021-12-08 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
4,000 -45.8%
40.00
US$160,000 		4,000 -45.8% 40.00 US$160,000
2021-11-17 2021-11-15 PlS Planned sale
2.1
Martin Samuel Bates

SVP and CFO

Officer
2,048 -7.1%
42.27
US$86,569 		2,048 -7.1% 42.27 US$86,569
2021-11-17 2021-11-15 PlS Planned sale
2.1
Martin Samuel Bates

SVP and CFO

Officer
7,452 -20.5%
43.92
US$327,314 		7,452 -20.5% 43.92 US$327,314
2021-11-16 2021-11-12 S Sale
3.1
Young Diane C.

SVP, Chief Medical Officer

Officer
4,600 -68.5%
42.94
US$197,529 		4,600 -68.5% 42.94 US$197,529
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
1,189 -20.1%
41.62
US$49,481 		1,189 -20.1% 41.62 US$49,481
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
600 -9.2%
43.11
US$25,868 		600 -9.2% 43.11 US$25,868
2021-11-03 2021-11-01 PlS Planned sale
1.7
Crowley Elizabeth

Sr. VP &CPDO

Officer
2,528 -28.0%
44.12
US$111,525 		2,528 -28.0% 44.12 US$111,525
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
2,120 -83.9%
41.62
US$88,232 		2,120 -83.9% 41.62 US$88,232
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
901 -26.3%
43.06
US$38,798 		901 -26.3% 43.06 US$38,798
2021-11-03 2021-11-01 PlS Planned sale
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
4,302 -55.6%
44.11
US$189,774 		4,302 -55.6% 44.11 US$189,774
2021-11-03 2021-11-01 PlS Planned sale
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
600 -5.1%
41.71
US$25,026 		600 -5.1% 41.71 US$25,026
2020-12-16 2020-12-14 S Sale
2.2
Wright Richard M.

Sr. VP & CCO

Officer
9,375 -97.8%
18.61
US$174,436 		9,375 -97.8% 18.61 US$174,436
2020-12-16 2020-12-14 S Sale
2.2
Wright Richard M.

Sr. VP & CCO

Officer
11,457 -98.2%
18.61
US$213,175 		11,457 -98.2% 18.61 US$213,175
2020-06-12 2020-06-11 B Purchase
3.1
Young Diane C.

SVP, Chief Medical Officer

Officer
2,115 +inf%
4.73
US$10,004 		2,115 +inf% 4.73 US$10,004
2020-06-11 2020-06-10 B Purchase
3.0
Cavanaugh Sarah

SVP of Corp Affairs & Admin.

Officer
1,050 +331.2%
4.83
US$5,072 		1,050 +331.2% 4.83 US$5,072
2020-06-10 2020-06-09 B Purchase
2.7
KELER TIBOR

Executive VP & CSO

Officer
5,000 +212.1%
2.99
US$14,954 		5,000 +212.1% 2.99 US$14,954
2020-06-10 2020-06-09 B Purchase
3.8
MARINO JAMES J
Non-Executive Director
8,305 +188.8%
3.00
US$24,915 		8,305 +188.8% 3.00 US$24,915
2020-06-10 2020-06-09 PP Planned purchase
2.1
Martin Samuel Bates

SVP and CFO

Officer
9,750 +989.8%
3.05
US$29,738 		9,750 +989.8% 3.05 US$29,738
2020-06-10 2020-06-09 PP Planned purchase
2.4
Marucci Anthony S

President & CEO

Executive Director
15,000 +338.0%
3.06
US$45,900 		15,000 +338.0% 3.06 US$45,900
2020-06-10 2020-06-09 B Purchase
2.7
Heath-Chiozzi Margo

SVP of Regulatory Affairs

Officer
1,000 +inf%
3.01
US$3,005 		1,000 +inf% 3.01 US$3,005
2018-08-28 2018-08-24 B Purchase MARINO JAMES J Non-Executive Director
40,000 +153.9%
0.48
US$19,200 		40,000 +153.9% 0.48 US$19,200
2018-06-18 2018-06-15 B Purchase KELER TIBOR

Executive VP & CSO

Officer
16,500 +87.4%
0.59
US$9,783 		16,500 +87.4% 0.59 US$9,783
2016-09-06 2016-09-02 B Purchase KELER TIBOR

Executive VP & CSO

Officer
3,000 +18.9%
3.32
US$9,960 		3,000 +18.9% 3.32 US$9,960
2015-11-25 2015-11-23 PlS Planned sale CATLIN AVERY W

Sr. VP & CFO

Officer
25,000 -41.6%
18.00
US$450,000 		25,000 -41.6% 18.00 US$450,000
2015-08-26 2015-08-25 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +10.3%
14.00
US$70,000 		5,000 +10.3% 14.00 US$70,000
2015-08-21 2015-08-20 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +11.5%
15.00
US$75,000 		5,000 +11.5% 15.00 US$75,000
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
2,500 +6.1%
15.96
US$39,900 		2,500 +6.1% 15.96 US$39,900
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
2,200 +5.7%
15.94
US$35,068 		2,200 +5.7% 15.94 US$35,068
2015-08-19 2015-08-18 B Purchase ELLBERGER LARRY Non-Executive Director
300 +0.8%
15.93
US$4,779 		300 +0.8% 15.93 US$4,779
2015-08-14 2015-08-13 B Purchase ELLBERGER LARRY Non-Executive Director
5,000 +14.9%
16.59
US$82,950 		5,000 +14.9% 16.59 US$82,950
2015-06-16 2015-06-15 PlS Planned sale CATLIN AVERY W

Sr. VP & CFO

Officer
25,000 -50.4%
24.59
US$614,752 		25,000 -50.4% 24.59 US$614,752
2013-12-10 2013-12-06 S Sale LIPTON KAREN SHOOS Non-Executive Director
17,728 -57.1%
24.50
US$434,336 		17,728 -57.1% 24.50 US$434,336
2013-12-10 2013-12-06 S Sale PENNER HARRY JR Non-Executive Director
17,728 -56.9%
24.50
US$434,336 		17,728 -56.9% 24.50 US$434,336
2013-12-10 2013-12-06 S Sale ELLBERGER LARRY Non-Executive Director
17,728 -41.5%
24.50
US$434,336 		17,728 -41.5% 24.50 US$434,336
Explore more

More insider trading research around Celldex Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America